AMRS Stock - Amyris Inc.

AMRS Stock Chart

AMRS Profile

Amyris, Inc., a pioneering synthetic biotechnology firm, operates within the global markets of clean health and beauty, as well as flavors and fragrances across Europe, North America, Asia, and South America. The company specializes in manufacturing and distributing a diverse range of clean beauty, personal care, health, wellness consumer products, and ingredients. Amyris serves various industries including flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care, offering products under well-known brands such as Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN.

Beyond consumer goods, Amyris, Inc. collaborates with the Infectious Disease Research Institute to advance the development of a COVID-19 vaccine, showcasing its commitment to leveraging biotechnology for global health solutions. Originally named Amyris Biotechnologies, Inc., the company rebranded as Amyris, Inc. in June 2010, reflecting its expanded focus and evolution in the biotechnology sector.

Established in 2003 and headquartered in Emeryville, California, Amyris continues to lead the field of synthetic biology, integrating cutting-edge technology to innovate sustainable solutions across diverse markets. The company's strategic collaborations and robust product portfolio underscore its role in driving advancements in clean beauty, health, and wellness while addressing critical global challenges.

AMRS Revenue Chart

AMRS Earnings

Analyst Ratings